The American College of Cardiology (ACC) has released a new Expert Consensus Decision Pathway (ECDP) on the use of anticoagulant and antiplatelet therapy in patients with atrial fibrillation (AF) or ...

Clinicians have a new tool to help them in deciding how best to balance risks and benefits when there’s a need to mix anticoagulation and antiplatelet therapy in patients with A-fib or venous ...

Patients with chronic coronary syndromes derive a benefit from low-dose rivaroxaban (Xarelto; Bayer/Janssen) plus aspirin regardless of whether they’ve undergone PCI in the past, the COMPASS-PCI study ...

(Boston)— Researchers have identified a potential new signaling pathway and enzyme that may help further the understanding of blood clot formation in chronic kidney disease patients and ultimately be ...

Current antithrombotic agents impair haemostasis, which increases the risk of bleeding. A new study now reveals a novel target with antithrombotic potential and with reduced risk of bleeding. “We have ...

The process of forming a blood clot is called coagulation. Coagulation is a key player in the repair and maintenance of the circulatory system. However, in some cases, such as major surgery, there is ...